Navigation Links
Cambridge Semantics Named 2013 SIIA CODiE Award Finalist

Boston, MA (PRWEB) March 21, 2013

Cambridge Semantics has been named a finalist in the 2013 SIIA CODiE Awards. The company’s Anzo Pharma Competitive Intelligence Solution has been recognized in the highly competitive category of Best Business Intelligence/Analytics Solution. As the industry’s only peer-reviewed awards program, the SIIA CODiE Awards are the premier award for the software and information industries and have been recognizing product excellence for 27 years.

The Cambridge Semantics Anzo Pharma Competitive Intelligence Solution is currently in use at some of the world’s top biopharma organizations where R&D teams, business development, marketing and knowledge management groups are tasked with delivering critical competitive intelligence information. Based on Semantic Web technologies, Cambridge Semantics delivers Unified Information Access (UIA) solutions that enable these groups to easily route targeted information to the right people at the right time from the right sources incorporating both structured and unstructured data. This kind of broad and deep view of data gives scientists, business analysts, safety officers, managers, directors, and executives timely access to data that informs their decision-making, wherever the data may be.

“Pharmaceutical companies are facing a crippling data diversity challenge as they struggle to integrate traditional structured data with unstructured text and semi-structured content to make business decisions. Unified Information Access solutions like our Anzo Competitive Intelligence solution allow business users to get immediate and integrated access to all data relevant to critical business decisions, regardless of its location and format,” said Lee Feigenbaum, Vice President of Marketing and Technology at Cambridge Semantics. “We are honored to be recognized by SIIA for our innovative approach to helping pharmaceutical organizations solve their most pressing data challenges.”

Winners will be announced during a special Awards luncheon on May 9, 2013 in San Francisco during the All About the Cloud conference.

To learn more about Cambridge Semantics visit

About Cambridge Semantics
Cambridge Semantics provides the award-winning Anzo software suite, an open platform for building interactive Unified Information Access (UIA) solutions. Enterprises face an increasing need to rapidly discover, understand, combine, and act on data from diverse sources both from within and across organizational boundaries. Anzo makes it easy for both IT and end users to deal with this need by rapidly creating solutions that leverage unified access to structured and unstructured data from varied sources in the context of specific business problems.

Cambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit or follow us on Twitter @CamSemantics.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
2. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
3. Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy
4. Stevenage Bioscience Catalyst to Welcome Cambridge University Researchers
5. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
6. Archie Cullen Named President of BioReliance
7. SoundConnect Named Best 2012 Conferencing Provider by Telecom Association
8. Adeptia Named a Value Leader in EMA Radar for Integration Technologies for Hybrid Cloud: Q4 2012
9. uniQure Named to MIT Technology Reviews 2013 50 Disruptive Companies List Recognizing Worlds Most Innovative Companies
10. Ernest Mario, Ph.D., Named Chairman of Chimerix, Inc.
11. Research article coauthored by Pitt professor named best article of the year by Science
Post Your Comments:
(Date:11/30/2015)... and MAGDEBURG, Germany , November 30, ... (ECNR) in Vienna, Austria to ... Congress of NeuroRehabilitation (ECNR) in Vienna, Austria ... NovaVision, a wholly owned subsidiary of Vycor Medical, Inc. ... of its Internet-delivered NovaVision Therapy Suite at the 3rd ...
(Date:11/28/2015)... ... 2015 , ... • Jeon Jin Bio Corp, a Korean Biotech venture company, ... , Bird Free, an oil-based, gel formula made ... including visual, smell, taste and touch, enabling safe, effective avian control without toxic chemicals ...
(Date:11/26/2015)... 2015 ... Research Laboratories, a leading independent and ... has formed a strategic partnership with ... Health for joint work on clinical ... ) , --> ,     ...
(Date:11/25/2015)... 25, 2015 2 nouvelles études permettent ... les différences entre les souches bactériennes retrouvées dans la ... des êtres humains . Ces recherches  ouvrent une nouvelle ... prise en charge efficace de l,un des problèmes ... chats .    --> 2 nouvelles études ...
Breaking Biology Technology:
(Date:11/17/2015)... Nov. 17, 2015 Pressure BioSciences, Inc. (OTCQB: ... development and sale of broadly enabling, pressure cycling technology ... industry, today announced it has received gross proceeds of ... Private Placement (the "Offering"), increasing the total amount raised ... more additional closings are expected in the near future. ...
(Date:11/11/2015)... Minn. , Nov. 11, 2015   MedNet Solutions ... entire spectrum of clinical research, is pleased to announce that ... in Clinical Trials (PCT) event, to be held November ... be able to view live demonstrations of iMedNet ... and learn how iMedNet has been able to ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
Breaking Biology News(10 mins):